This might include a breast lift to reposition sagging tissue, augmentation to restore lost volume, or a combination of both
Weight loss achieved through Zepbound therapy may ultimately improve reflux symptoms over time, as excess abdominal weight is a major risk factor for GERD
Secondary endpoints were TBWL% at 1, 2 and 3 years, lipid profile, blood pressure, hemoglobin A1c, fasting plasma glucose, mental health, serious adverse events, quality of life, cardiovascular morbidity and mortality, remission of obesity-related complications and all-cause mortality
Semaglutide We offer up to 2mg/week (as medically appropriate) for an additional $100 per month
The April 2026 TGA alert regarding unapproved GLP-1 receptor agonists (including Retatrutide) reinforced the distinction between therapeutic use, which remains unapproved, and research-grade supply for laboratory purposes, which is legally distinct under Australian law